Top news of the week: 23.08.2022.
Ex-Google CEO’s VC firm brings in hype-busting researcher to expand its biotech investments
Innovation Endeavors, the VC firm cofounded by former Google chairman and CEO Eric Schmidt, is bringing in one of the few researchers who saw through Theranos to help expand its biotech ...
Biopharma Will Learn to Embrace Machine Learning
With the effective incorporation of inter-disciplinary fields, machine learning might be commonly used in the biopharma industry in the upcoming 5–10 years.
Biotech Rebounds on Optimism and Deal Making
The sector had tumbled in the market selloff, but it is getting a boost from big investors and big pharmaceutical companies.
Schrödinger names longtime biotech analyst Porges its CFO and top dealmaker
Geoffrey Porges, who has spent nearly two decades researching biotechs at SVB Securities and AllianceBernstein, will now oversee and seek to grow the drug discovery specialist's network of ...
State of Biopharma Tech Q2’22 Report
Investment in global biopharma tech fell to its lowest level in recent years. Discover key trends shaping the space.
Moderna, after firing newly hired CFO, finds replacement in PerkinElmer executive
The COVID-19 vaccine maker has appointed James Mock, currently PerkinElmer’s CFO, as its next finance head, three months after ousting Jorge Gomez from the role.
About OUTbio
OUTbio is the biotech industry’s largest LGBTQ professionals group. Our mission is to empower the LGBTQ community and its allies in biotechnology and affiliated …
Next-generation RNA technologies: making longer-lasting drugs with a broader reach
At least 10 biotechnology startups are trying to use RNA molecules in new ways to make medicines. Here’s a look at where they stand.